Trump ’s aggressive advocacy of malaria drug for treating coronavirus divides medical community
Trump himself has a small personal financial interest in Sanofi, the French drugmaker that makes Plaquenil, the brand-name version of hydroxychloroquine.
Source: The Economic Times - Category: Consumer Health News Source Type: news
More News: American Health | Coronavirus | COVID-19 | France Health | Health | Hydroxychloroquine | Malaria | Trump | USA Health